Hadron Therapy Workshop: status and perspectives, plans for next generation facilities 18-19 October 2024
Zoom
Webcast Link: https://webcast.cern.ch/view/wyxgrrnoendlmwbp/1431627
Scientific Assistants: Elpida Theodoridou (Uni Malta/DKFZ) chair, Nermine Muradi (Uni Tetova) chair, Alexandros Puckett Anastasiou (Uni Patra), Athanasios Athanasiou (AUTh), Christina Litou (AUTh), Dafni Giannakeri (AUTh), Effrosyni Chatzivasiloglou (AUTh), George Ntinas (AUTh), Maria Eleni Bozika (AUTh), Maria Vagianni (AUTh), Emina Huko (UNSA), Feriha Babic (UNSA), Naida Ustavdic (UNSA), Medina Dugonjic (UNSA), Danis Bradaric (UNSA).
-
-
SESSION 1 - HADRON THERAPY OVERVIEW
Moderators: Manjit Dosanjh, Yiota Foka
-
1
Participants registration
-
2
Welcome Addresses
Maria Bigaki (IAEA CP, Papageorgiou), Michail Karaviotis ( Papageorgiou),
Sotirios Charisopoulos (IAEA), Sandro Rossi (HITRIplus, CNAO),
Panagiotis Bamidis (AUTH,/AHEPA, ELEVIT) -
3
Historic and scientific evolution of Hadron TherapySpeakers: Ugo Amaldi (TERA Foundation (IT)), Sandro Rossi (CNAO)
- 4
-
5
Radiobiology of Hadron TherapySpeaker: Angelica Facoetti (CNAO)
-
6
HITRIplus project, its impact on boosting research in South East Europe and future perspectivesSpeaker: Sanja Damjanovic (SEEIIST Association (CH) / GSI)
-
7
Building capacity through the IAEA programsSpeaker: Sotirios Charisopoulos (IAEA)
-
10:55 AM
Coffee Break
-
1
-
SESSION 2 – HADRON THERAPY DEVELOPMENTS AND FUTURE PERSPECTIVES
Moderator: Roberto Orecchia
-
8
Hadron Therapy : from pioneering times towards the futureSpeaker: Manjit Dosanjh (University of Oxford (GB))
-
9
SEEIIST facility design and alternativesSpeaker: Maurizio Vretenar (CERN)
-
10
CERN as an example of large scale infrastructureSpeaker: Emmanuel Tsesmelis (CERN)
-
11
Status and vision of the SEEIIST projectSpeaker: Leandar Litov (University of Sofia - St. Kliment Ohridski (BG))
- 12
-
13
Round table – SEEIIST towards to the Future
Moderators: Sotirios Charisopoulos (IAEA), Sandro Rossi (HITRIplus, CNAO)
Panelists: Maurizio Vretenar (CERN), Semi Harrabi (HIT)
Contributions: Introduction, cancer incidence in SEE Mimoza Ristova (Uni Skopje) -
1:45 PM
Lunch Break
-
8
-
SESSION 3 – EXPERIENCES OF MULTIPARTICLE THERAPY FACILITIES IN OPERATION IN EUROPE
Moderator: Angelica Facoetti
-
14
Hadron Therapy at GSI - where we come from, where we goSpeaker: Konrad Lehmann (GSI)
-
15
The HIT facility, technology, clinical applications and research: novel approaches in particle therapySpeaker: Andrea Mairani (HIT)
-
16
The Krakow Hadron Therapy facility, lessons learntSpeaker: Pawel Olko (IFJ - PAN)
-
17
Concluding remarksSpeaker: Angelica Facoetti (CNAO)
-
4:30 PM
Coffee Break
-
14
-
SESSION 4 – ADVANCES IN ACCELERATOR TECHNOLOGIES FOR HADRON THERAPY FACILITIES
Moderator: Laura Vallow
-
18
Accelerator and beam physics developments for medical and societal applications at CERNSpeaker: Alessandra Lombardi (CERN)
-
19
Innovative gantry designs: Superconducting magnets for advanced gantrySpeaker: Ernesto De Matteis (INFN)
-
20
Innovative gantry designs-continuedSpeaker: Ariel Haziot (CERN)
-
21
Optimisation for pre-injectors for hadron therapy-AMSpeaker: Aristeidis Mamaras (Aristotle University of Thessaloniki / CERN)
-
22
An ion source project as a seed to build capacity for next generation accelerator physicists in Bosnia-and-HerzegovinaSpeakers: Amer Ajanovic (CERN/UNSA), Danis Bradaric (UNSA), Medina Dugonjic (UNSA), Naida Ustavdic (UNSA)
-
23
Development of the first table-top X-ray FLASH systemSpeakers: Ms ELPIDA THEODORIDOU (DKFZ / Uni Malta), Joao Seco (DKFZ)
-
24
Concluding remarksSpeaker: Laura Vallow (Mayo Clinic)
- 25
-
18
-
-
-
Session 5 – INDICATIONS FOR HADRON THERAPY: Indications and clinical applications of HT
Moderators: Arnold Pompos, Joao Seco
-
26
Chordoma treatments at CNAOSpeaker: Maria Rosaria Fiore (CNAO)
-
27
Sarcoma treatments in GreeceSpeaker: Tasos Kyriazoglou (Attikon University Hospital)
-
28
Radiosurgery for Skullbase MeningiomSpeaker: Christos Boskos (ST. LUKE'S)
-
29
SRS Treatment Planning for Endocranial TumorSpeaker: Anna Makridou
-
30
Personalization of hadron therapy for radioresistant cancers through bioindicators of radioresistance or conditional vulnerabilitySpeaker: Michael Story (Mayo Clinic)
-
31
Concluding remarksSpeakers: Arnold Pompos (UT Southwestern, Dallas, TX), Joao Seco (DKFZ)
-
11:05 AM
Coffee Break
-
26
-
SESSION 6 – SOCIO-ECONOMIC ASPECTS RELATED TO HADRON THERAPYConvener: Sandro Rossi (Fondazione CNAO)
-
32
Hadrontherapy and EU clinical networks: status and perspectivesSpeaker: Lisa Licitra (CNAO, Uni Milan)
-
33
Costs of hadrontherapy, the ABC analysis applied to operations in CNAOSpeaker: Maria Vittoria Livraga (CNAO)
-
34
Caring for cancer patients: the CNAO social approachSpeaker: Silvia Meneghello (CNAO)
-
35
The role of citizens in innovating healthSpeakers: Katerina Zourou (Web2Learn), Stefania Oikonomou (Web2Learn)
-
36
The role of biomedical and clinical engineering societies in advancing and promoting Hadron Therapy on a national and international levelSpeaker: Alkinoos Athanasiou (AUTH, ELEVIT)
-
37
Challenges and Opportunities in the Patient's Pathway to AccessSpeaker: Menia Koukougianni (NGO KARKINAKI)
-
38
Empowering patient advocacy and cancer preventionSpeaker: Panagiotis Bamidis (AUTH/AHEPA, ELEVIT)
-
39
Concluding remarksSpeaker: Sandro Rossi (CNAO)
-
1:40 PM
Lunch Break
-
32
-
SESSION 7 – PEDIATRIC ONCOLOGY AND ROLE OF HADRON THERAPY
Moderators: Antonio Capizzello, Emmanouel Chatzipantelis, Eugenia Papakonstantinou, Semi Harrabi
-
40
Carbon Programme in MedAustronSpeaker: Piero Fossati (MedAustron)
-
41
Pediatric Treatments in MedAustronSpeaker: Carola Lütgendorf-Caucig (MedAustron)
-
42
Hadron therapy state-of-the art in pediatric oncology-clinical aspectsSpeaker: Sabina Vennarini (CNAO)
-
43
Treatment planning for pediatric cancer tumour treatmentsSpeaker: Alfredo Mirandola (CNAO)
-
44
Pediatric brain tumour surgery : where do we stand?Speaker: Nikos Foroglou (AUTH/AHEPA)
-
45
Role of surgery in pediatric soft tissue sarcomaSpeaker: Aikaterini Tzantzaroudi (Hippokration Hospital)
-
4:30 PM
Coffee Break
-
46
Panel discussion: Paediatric Oncology in Greece
-
47
Clinical profile of pediatric oncology patients managed and treated in Pediatric Haematology and/or Oncology Unit University Hospital AHEPASpeaker: Emmanouel Chatzipantelis (AUTH/AHEPA)
-
48
Clinical profile of pediatric oncology patients managed and treated in Pediatric Haematology and/or Oncology Unit Hospital Hippoktateio HospitalSpeaker: Evgenia Papakonstantinou (Hippokrateio Hospital)
-
49
Pediatric patients commonly referred for external beam RadiotherapySpeakers: Antonio Capizzello (AUTH / AHEPA), Eftychia Tataridou (Theageneio Hospital)
-
50
The spectrum of pediatric patients referred for ProtontherapySpeaker: Barbara Rombi (APSS - TRENTO)
-
51
Radiation treatment plan for pediatric cancer: a clinical viewSpeaker: George Giakoumetis (AUTH/AHEPA)
-
52
Concluding remarksSpeaker: Semi Harrabi (HIT)
-
40
-